Dr Nieusma: Deaths Accelerating, We Must Prepare & Protect our Loved Ones

Dr. Joe Nieusma returns to the program to share the latest on the depopulation and the death jab agenda. Unfortunately, it is becoming clear that deaths will continue to accelerate and the cause of death will continue to be deflected by the powers that be who control the mass media, the medical establishment and the political establishment. People must know there is hope if you prepare and protect your body from additional harm. You can contact Dr. Joe at SuperiorToxicology.com   See Important Proven Solutions to Keep Your from getting sick even if you had the mRNA Shot - Dr. Nieusma Learn more about the Nobel prize winning technology behind Govvi & how to save serious money on Gas: GOVVI.com/go/helpmesave See exclusive interviews on SarahWestall.TV or on Ebener (what is Ebener?)! Sign up at SarahWestall.com/Subscribe MUSIC CREDITS: "Cinematic Trailer" Media Music Group & "Do You Trust Me" by Michael Vignola, licensed for broad internet media use, including video and audio     See on Bastyon | Odysee | Bitchute | Rumble | SarahWestall.tv | Freedom.Social     Dr. Joe Nieusma Biography Dr. Joe Nieusma is our fearless CEO/Chief Toxicologist here at Superior Toxicology & Wellness, an international scientific consulting firm that he founded. Dr. Nieusma is also a co-founder for TwinOxide North America, a company working to improve water quality in all aspects of life from municipal treatment plants to livestock operations. TwinOxide removes all carcinogens from treated water and is the right thing to do. Dr. Nieusma is a member of the Scientific Advisory Board for Vitro Biopharma, a firm that brings new stem-cell related products for diabetes research to scientific, pharmaceutical, and ultimately medical markets.  Dr. Nieusma is also on the editorial staff for the peer-reviewed scientific journal, Toxicology Mechanisms and Methods, published by Informa Healthcare. Dr. Nieusma was a Senior Toxicologist for Affygility Solutions from October 2005 to February 2018. Affygility is a company providing strategic environmental health and safety solutions to life science companies.  Dr. Nieusma left Affygility to focus on Superior Toxicology & Wellness, as well as TwinOxide-Colorado. Dr. Nieusma was an Industrial Toxicologist for Sandoz (formerly Geneva Pharmaceuticals) from May of 1998 to April of 2004. He left Sandoz to open Superior Toxicology & Wellness. Dr. Nieusma has participated as an editorial board member for Micromedex, Inc. since May of 2001 primarily to provide toxicological evaluation of potential new products and databases as needed.  Dr. Nieusma has participated in research for a human health risk assessment involving over 100 chemicals of interest from a US Naval incinerator in Osaka, Japan. Dr. Nieusma worked for Dow Chemical in the Biotransformation group from September 1989 until July 1991. Dr. Nieusma earned his B.S. from Central Michigan University with a major in pre-med biology and a minor in chemistry.  He went on to earn a Ph.D. in Pharmaceutical Sciences from the University of Colorado, School of Pharmacy and the Molecular Toxicology and Environmental Health Sciences Program.  The title of his dissertation research is “Stereochemical aspects of 1,3-Butadiene Metabolism and Toxicity”. His research characterized the very different pattern of metabolism and toxicity mainly due to the orientation of various side chains around chiral carbons of a small molecule hydrocarbon with multiple double bonds. Dr. Nieusma has been actively involved in toxicology research for the past 30 years with six published manuscripts. The majority of his work, especially in the pharmaceutical industry and consulting, has been conducted in an industrial setting and published only within the company or to a client. These potent compound classification reports for pharmaceutical agents were written to assess occupational hazards that may exist during the manufacturing process for a d... See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.